Our healthcare team helps major research institutions, medical centers, hospitals, health systems and physicians on innovative and cost-effective ways of delivering patient services. We handle transaction, financing, litigation and regulatory matters for such clients as Texas Medical Center, Parkland Center for Clinical Innovation, Adventist Health Systems, CHRISTUS Health, M.D. Anderson and The Menninger Clinic.
Through their years of experience, both in-house and in private practice, our lawyers understand the compliance and regulatory challenges faced by healthcare providers on a daily basis. We work with providers in developing compliance programs that meet state and federal regulations. We also provide guidance on regulatory disclosures and, when necessary, develop corrective actions in response to agency audits and surveys.
We represent health systems and other healthcare entities in mergers and acquisitions, divestitures and the formation of joint ventures and strategic relationships, as well as related financings. In 2018, for example, we represented Presbyterian Village Northwest in successfully closing a $91.8 million bond, as well as Brazos Presbyterian Homes and BPH Holding in the acquisition of Longhorn Village in Austin, Texas. We currently are represented Texas Medical Center in the $2 billion development of a 30-acre biomedical innovation and commercialization campus known as TMC3.
Bracewell has a number of seasoned lawyers who represent individuals and entities in the healthcare industry who are the target of investigations and enforcement actions by state and federal health agencies. Our lawyers conduct internal investigations, defend clients in criminal, civil and regulatory investigations or prosecutions and assist with corporate compliance programs. We also advise academic institutions, health plans, pharmaceutical/device manufacturers and other clients on contracting with federal agencies such as DOD, VA, HHS, and GSA, including FAR counseling.
Our IP team represents healthcare providers in all phases of product development, from early-stage funding to exit transactions, as well as licensing, technology transfers and outsourcing. We recently represented the University of Texas MD Anderson Cancer Center in negotiating a sublease agreement involving intellectual property issues related to the development of new cancer therapies.
Bracewell has extensive experience representing healthcare providers in malpractice suits and commercial disputes. We currently are representing The Medicines Company (Medco) in an international arbitration over an $80 million licensing dispute with a Japanese biopharmaceutical company.
Healthcare spending in the US accounts for over 17 percent of gross domestic product and is expected to be a $4 trillion dollar industry by 2021. Bracewell’s team of healthcare lawyers advises major research institutions, academic medical centers, hospitals, health systems, surgery centers, physicians, physician practices, healthcare clinics, life science companies, non-profit corporations, charitable trusts and all other healthcare-related enterprises, on a wide variety of matters relating to corporate governance, strategic relationships and partnerships, finance, employee relations, data security, medical records maintenance, regulatory compliance, tax, antitrust, intellectual property matters, and litigation. We work with our clients to secure financing for new and expanded operations, monetize intellectual property assets, develop and execute electronic record management, mergers and acquisitions, and ensure effective corporate governance.
Our integrated team counsels our clients on operational and transactional healthcare compliance, including matters arising under the Affordable Care Act (ACA), the Health Insurance Portability and Accountability Act (HIPAA), the Stark Law, the federal “Anti-Kickback” Statute, the Civil Monetary Penalties Law, the False Claims Act, and laws governing the corporate practice of medicine. We also regularly advise clients in the healthcare industry with respect to managed care contracts, affiliation agreements, clinic coverage agreements, data collaboration agreements, contracts between physicians, hospitals, and other health-care enterprises, and the formation of joint ventures. We also possess significant experience in defending clients in civil, criminal and/or regulatory investigations and prosecutions from both state and federal healthcare regulators, including investigations and prosecutions involving the Department of Justice, the Office of Inspector General of the Department of Health & Human Services (HHS), the Internal Revenue Service (IRS), and various states’ Attorneys General. Our attention is on our clients’ business so that they can focus on what they do best—treating patients and curing disease.
Bracewell represents insureds, not insurance companies. We advise clients around the world seeking coverage under almost every kind of commercial insurance policy, assisting them in getting the most out of their coverage by negotiating and litigating as needed to achieve the most advantageous results. Our team has a proven track record of doing this against major insurers across the globe. We are strong advocates for our clients and always mindful of any commercial concerns that may influence how we approach a given matter.
With a deep understanding of the insurance business and the needs of our clients, Bracewell’s team is recognized as a go‐to coverage firm by leading international insurance brokers and consultants, who frequently refer their clients to us when coverage issues arise. Our lawyers have helped clients recover by obtaining policy proceeds from major disasters such as:
- the 9/11 terrorists attacks
- accounting scandals
- virtually every hurricane and named storm in the US and Caribbean over the last 20 years
- other natural disasters, such as the 2011 Tōhoku earthquake and tsunami in Japan
- the Deepwater Horizon oil spill
- major wildfires in California and Texas
- business-threatening cyberattacks
Bracewell’s tax-exempt organizations team regularly advises a wide range of nonprofit corporations and charitable trusts about the applicable complex rules and regulations. We routinely advise clients about various federal tax issues, such as compliance with the private inurement proscription, the private benefit limitation, excise taxes applicable to private foundations and related persons, the lobbying and electioneering rules, structuring investments to avoid unrelated business income tax, IRS examinations and rulings, and tax-exempt finance. In addition, we provide legal guidance to nonprofit corporations in connection with a variety of business transactions, such as mergers and acquisitions, sales and purchases of physician practices, and debt offerings. Finally, we help clients comply with board governance issues, such as drafting and interpreting governance documents and policies, and negotiating gift and naming rights agreements with donors.
Our nonprofit clients include hospitals and healthcare organizations, colleges and universities, independent and parochial schools, museums and arts organizations, conservation organizations, advocacy groups, student loan organizations, and grant-making foundations and charitable trusts.
Recent Notable Matters
Houston Methodist — healthcare disclosure counsel in connection with the issuance of $530 million Houston Methodist Taxable Revenue Bonds, Series 2020A and $370 million Harris County Cultural Education Facilities Finance Corporation Tax-Exempt Revenue Bonds (Houston Methodist), Series 2020B to finance and refinance improvements to hospitals and other health care facilities
Healthcare organization — guidance relating to the rules and regulations enacted as part of the Affordable Care Act, including Internal Revenue Code Section 501(r)
Healthcare organization — structured joint ventures and partnerships with for-profit entities to protect continued tax-exempt status of exempt participants
Hermann Hospital — negotiations with the IRS involving the hospital’s participation in certain physician recruitment activities, resulting in a closing agreement with the IRS that contained detailed physician recruitment guidelines, serving as the forerunner to Revenue Ruling 97-21 dealing with physician recruitment
Independent, non-profit biomedical research institution — draft and negotiate a variety of research and data sharing agreements and develop patent portfolio to facilitate institutional interests regarding the effects of human genetics on health outcomes and development of diagnostics and therapeutics for combating infectious diseases
Major hospital systems — creation of whole hospital joint ventures combining health care activities of the nonprofit systems with the operations of investor-owned hospital systems, structured to address control requirements necessary to preserve the nonprofit hospital systems' continuing tax-exempt status
Medical research and development institutions — prepare and prosecute patent and trademark applications relating to biological compositions and processes involving nucleic acids, antibodies, cell lines, and pharmaceutical formulations
Multi-hospital health care system — IRS examination of client’s partnerships with proprietary health care providers
Numerous non-profit hospitals, long-term care facilities, and other healthcare facilities — borrowings and restructurings, including synthetic fixed-rate refundings, direct placement financings, new money financings, and post-issuance remedial action
Parkland Center for Clinical Innovation (PCCI) — sophisticated and complex spin-off transaction involving the licensing of software to Pieces Technologies, Inc. (Pieces Tech), an innovative healthcare analytics entity that deploys cutting-edge technology to improve clinical and community health outcomes; Pieces Tech officially launched with a $21.6 million Series A funding round led by Pacific Advantage Capital (PAC Partners) and Jump Capital, with participation from various healthcare systems and select Dallas family offices, among others
PreCheck, Inc. — sale to Cisive, a global provider of compliance-driven human capital management and risk management solutions
Predictive health intelligence company — a variety of intellectual property matters, including patent applications, licensing transactions with universities and corporations, and due diligence for strategic alliances with other genomic diagnostic companies
Privately Held Remote Pharmacy Company — recapitalization by private equity firms led by DFW Capital Partners, a New Jersey-based venture capital fund, and in prior private equity investment by NeighborCare, Inc. (now known as Omnicare, Inc.), as well as compliance matters governing remote pharmacies
Texas Hospital Network — designed FCPA policy and procedures for organization and its doctors to participate in joint ventures with various ministries of health in developing countries
Texas Medical Center — development of a 28-acre biomedical innovation and commercialization campus known as TMC3 which will be a cooperative development between the medical center and four public or non-profit medical institutions, including a world-renowned cancer center and a major public university’s health center
The Menninger Clinic — advise on all aspects of corporate governance, employee relations, HIPAA, data protection, intellectual-property management and monetization, and litigation defense
The University of Texas MD Anderson Cancer Center — broad exclusive licensing agreements and equity documents with respect to, among others, the following issuers: (a) Intrexon Corporation and ZIOPHARM Oncology; (b) Immatics US, Inc., with respect to structuring the initial round of a $60 million Series A financing round; and (c) OncoResponse, an immuno-oncology antibody discovery company that was launched jointly by MD Anderson and Theraclone Sciences, which led the Series A Preferred Stock round, and which included ARCH Venture Partners, Canaan Partners, William Marsh Rice University and Alexandria Real Estate Equities
Two major health care systems — IRS examinations of "acquisition financings" undertaken to facilitate the combination of previously unrelated health care systems to create the two systems, resolving both examinations in a manner that preserved the acquisition financing treatment and continued tax-exempt status of the bonds